Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility-Reference-Cited by-同舟云学术

Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility

Published:2015-07-08 Issue:3 Volume:11 Page:328-336
ISSN:1752-6981
Container-title:The Clinical Respiratory Journal
language:en
Short-container-title:The Clinical Respiratory Journal

Author:

Zhao Haijin¹,Li Rui¹,LV Yanhua¹,Dong Hangming¹,Yao Lihong¹,Wu Yue¹,Xiao Guanhua¹,Cai Shaoxi¹

Affiliation:

1. Department of Respiratory and Critical Care Medicine, Chronic Airways Diseases Laboratory; Nanfang Hospital, Southern Medical University; Guangzhou 510515 China

Funder

National Natural Science Foundation of China

National Program on Key Basic Research Project

Special Project on the Integration of Industry, Education and Research of Guangdong Province

Nanfang Hospital President Foundation

Publisher

Wiley

Subject

Genetics(clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/crj.12340/fullpdf

Reference35 articles.

1. Clinical aspects of using exhaled NO in asthma diagnosis and management;Ludviksdottir;Clin Respir J,2012

2. Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates;Donohue;Respir Med,2013

3. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications;Dweik;Am J Respir Crit Care Med,2011

4. Responsiveness to methacholine, but not leukotriene D4, correlates with fractional exhaled nitric oxide in asthma;Guan;Clin Respir J,2014

5. Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma;Gouw;Am J Resp Crit Care,1998

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia;World Allergy Organization Journal;2023-10

2. It is time to end our love affair with short-acting β₂-agonists in asthma;ERJ Open Research;2022-10

3. A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries;Pulmonology;2022-01

4. The Burden of Short-Acting β2-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA Program;Advances in Therapy;2021-05-27

5. A call to action for improving clinical outcomes in patients with asthma;npj Primary Care Respiratory Medicine;2020-12